WatchGov

New York bills · 2025 Regular Session

New York S 4587

Relates to prescription labels for mifepristone and misoprostol

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Cosponsors (1)

Summary

Official abstract published by the New York legislature

Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

Text versions

Roll-call votes

State vote data last updated Oct 16, 2026, 8:07 AM.

DateVoteResultYour legislators
Mar 4, 2025
Senate
Rules VotepassSet your home in New York to see

Actions